What is AVRO's current dividend yield?

AVRO (AVROBIO, Inc.) yields 142.86% based on an annual dividend of $2.00 per share at a stock price of $1.40. Dividends are paid quarterly.

How much does $10,000 in AVRO generate in dividends?

$10,000 invested in AVRO at 142.86% yield generates approximately $14285.71 per year, or $1190.48 per month in dividend income. With DRIP reinvestment, this compounds significantly over time.

How much does $50,000 in AVRO pay in dividends?

$50,000 in AVRO generates approximately $71428.57 per year at the current 142.86% yield.

Is AVRO a good dividend stock in 2026?

AVRO pays quarterly dividends with a 142.86% yield and 50% payout ratio. The 5-year dividend CAGR is 5%. The 50% payout ratio is considered sustainable. This is not financial advice.

Home › Calculator › AVRO Dividend Calculator 2026

AVRO Dividend DRIP Calculator 2026

142.86% YieldHealthcare

AVROBIO, Inc. · NASDAQ

Price: $1.40 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD

Annual dividend

$2.00

per share

Forward yield

142.86%

at current price

1Y div growth

+0%

CAGR

5Y div growth

+0%

CAGR

Payout ratio

50%

Sustainable

Calculator settings

ACCOUNT TYPE

INITIAL INVESTMENT

MONTHLY CONTRIBUTION$0/mo

$0$500$1k$2k

INVESTMENT HORIZON10 years

1y10y20y30y

PRICE GROWTH / YEAR0%

DIVIDEND GROWTH / YEAR0%

DRIP Reinvestment

Auto-reinvest all dividends

Monthly passive income

$3,498,473.96

after 10 years · DRIP ✓

Yield on cost: 419816.88%

Annual dividend income

$41,981,687.57

after 10 years

Total dividends: $71.36M

Real Yield · Inflation Adjusted

+140.06%= 142.86% yield − 2.8% CPI

iCalculated by subtracting the current 12-month CPI (2.8%) from the forward yield. Yield exceeds inflation — purchasing power is growing.

Portfolio (DRIP)

$71.37M

Portfolio (no DRIP)

$152.9K

DRIP bonus

+$71.22M

Total return

+713588.7%

📊 See how AVRO actually performed since 2021 →

Real historical prices · DRIP simulation · DCA backtest

Last 5 Years →

Year-by-year projection

DRIP ON ✓ · Roth IRA / ISA

Year	Shares	Annual income	Monthly income	Portfolio value	Yield on cost	Cumul. dividends
1	17,346.94	$14,285.71	$1,190.48	$24,286	142.86%	$14,286
2	42,128.28	$34,693.88	$2,891.16	$58,980	346.94%	$48,980
3	102,311.54	$84,256.56	$7,021.38	$143,236	842.57%	$133,236
4	248,470.88	$204,623.07	$17,051.92	$347,859	2046.23%	$337,859
5	603,429.27	$496,941.75	$41,411.81	$844,801	4969.42%	$834,801
6	1,465,471.08	$1,206,858.54	$100,571.55	$2,051,660	12068.59%	$2,041,660
7	3,559,001.20	$2,930,942.16	$244,245.18	$4,982,602	29309.42%	$4,972,602
8	8,643,288.62	$7,118,002.39	$593,166.87	$12,100,604	71180.02%	$12,090,604
9	20,990,843.78	$17,286,577.23	$1,440,548.10	$29,387,181	172865.77%	$29,377,181
10	50,977,763.48	$41,981,687.57	$3,498,473.96	$71,368,869	419816.88%	$71,358,869

Portfolio growth: DRIP vs No DRIP

Annual dividend income growth

💡 What-if scenarios

Click to apply scenario to the calculator

☕

Daily coffee money

+$150/mo for 15 years

$7874.20M

$385,990,006.96/month income

DCA bonus vs no DCA: +$1844.95M

📱

Skip one gadget/mo

+$100/mo for 20 years

$613259.26M

$30,061,728,302.28/month income

DCA bonus vs no DCA: +$103907.71M

🚀

Serious wealth mode

+$500/mo for 25 years

$86920737.69M

$4,260,820,475,060.57/month income

DCA bonus vs no DCA: +$43890669.52M

🎯 When AVRO pays your bills

Year your monthly dividend income covers each expense (based on current settings)

📺

Netflix

$18/month

✓ Year 1

🎵

Spotify

$11/month

✓ Year 1

📱

Phone bill

$60/month

✓ Year 1

🛒

Gas & groceries

$300/month

✓ Year 1

🚗

Car payment

$500/month

✓ Year 1

🏠

Rent (avg US)

$1,500/month

✓ Year 2

🏝️

Financial freedom

$5,000/month

✓ Year 3

Share your AVRO snowball 📈

$10,000 in AVRO → $71.37M in 10 years · $3,498,473.96/month

Post on X

About AVROBIO, Inc. (AVRO) — Dividend Analysis 2026

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Is AVRO a good dividend investment in 2026?

AVRO offers a 142.86% forward yield with a 50% payout ratio. Strand Safety Score: 0/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.

AVRO DRIP calculator — what's the difference?

With DRIP on a $10,000 investment over 10 years, your AVRO portfolio grows to $71.37M vs $152.9K without reinvestment. This is the compound interest effect in action.

AVRO dividend growth history & forecast

AVRO has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 142.86%.

Compare AVRO with similar stocks

⚖️ Compare AVRO vs SCHD →

Expert Reviewed byVictor StrandVERIFIED

This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.

📬

Get Your Full AVRO DRIP Report by Email

We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.

Free forever. No spam. Unsubscribe anytime.

Ready to invest? Open AVRO position with:

🛡️ Dividend Safety Analysis

Strand Safety Score™ — AVRO

Proprietary model · FCF Coverage (40) · Debt Leverage (30) · Earnings Momentum (30)

/100

Critical Risk

Cash Flow Coverage-8.1× coverage

0 / 40 pts

0/40

Company generates negative FCF ($-60M) — borrowing to pay dividends

Debt Leverage0.0× Debt/EBITDA

0 / 30 pts

0/30

Company not generating EBITDA — debt servicing risk is elevated

Earnings Momentum-0.1B → -0.1B → +0.0B

0 / 30 pts

0/30

Company is reporting net losses — dividend sustainability is in question

OVERALL ASSESSMENT

High risk of dividend cut — weak fundamentals across multiple factors.

STRAND SCORE

/100

Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.

🌍 AVRO Yield by Country & Account Type

Real after-tax yield depends on where you live and how you hold AVRO.

Gross yield

142.86%

Tax rate

15.00%

After-tax yield

121.43%

Real yield (−CPI)

118.63%

Account/Country	Tax Rate	After-tax Yield	Real Yield	$10K Annual Income
🇺🇸 Roth IRA / 401k	0%	142.86%	140.06%	$14,286 / yr
🇺🇸 US Taxable (15%) ✓	15%	121.43%	118.63%	$12,143 / yr
🇺🇸 US Taxable (20%)	20%	114.29%	111.49%	$11,429 / yr
🇬🇧 UK ISA	0%	142.86%	140.06%	$14,286 / yr
🇬🇧 UK Taxable	8.75%	130.36%	127.56%	$13,036 / yr
🇨🇦 TFSA	0%	142.86%	140.06%	$14,286 / yr
🇨🇦 CA Taxable	25%	107.15%	104.35%	$10,715 / yr
🇦🇺 Super (pension)	15%	121.43%	118.63%	$12,143 / yr
🇦🇺 AU Taxable	30%	100.00%	97.20%	$10,000 / yr
🇩🇪 DE Taxable	26.375%	105.18%	102.38%	$10,518 / yr
🇫🇷 FR Taxable	30%	100.00%	97.20%	$10,000 / yr

Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.

🎯 AVRO Income Goal & Break-Even

Dividend Break-Even

1yr

Years for dividends to fully repay your AVRO investment of $1.40/share (🇺🇸 US Taxable (15%) · 15.00% tax)

$10K invested · 10 Years

Dividends earned (DRIP)

$28.33M

Lost to inflation (2.8% CPI)

−$2.5K

Real purchasing power gain

$28.32M

12-month CPI (US BLS via FMP economic-indicators).

How much do I need to invest in AVRO for:

Shares needed

14,118

Capital required

$19,765

Monthly income

$2,000

Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).

📅 AVRO Dividend Payment Schedule

AVRO pays quarterly — 4 times per year. Next ex-div: TBD.

Jan

Feb

Mar

💰

Apr

May

Jun

💰

Jul

Aug

Sep

💰

Oct

Nov

Dec

💰

10 shares

$4.25 / payment

$17.00 / year after tax

100 shares

$42.50 / payment

$170.00 / year after tax

1,000 shares

$425.00 / payment

$1700.00 / year after tax

📊 AVRO vs Healthcare Benchmarks

How AVRO compares to typical Healthcare averages.

Benchmark: Healthcare

Dividend Yield▲+140.06% vs sectorBetter

AVRO

142.86%

avg

2.80%

5Y Dividend CAGR▼-6.80% vs sectorBelow avg

AVRO

0.00%

avg

6.80%

Payout Ratio▲-5.00% vs sectorBetter

AVRO

50.00%

avg

55.00%

Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AVRO sourced from FMP /financial-growth endpoint — real data, not estimates.

🏛️ AVRO Insider Activity

▲ 3 Buys

When executives buy their own stock, it's a signal they believe in the dividend's sustainability.

Insider	Title	Type	Date	Shares	Price	Total Value
Leonard Braden Michael	10 percent owner	Buy	2024-05-14	296,882	$1.30	$385.9K
Leonard Braden Michael	10 percent owner	Buy	2024-05-13	216,053	$1.26	$272.2K
Leonard Braden Michael	10 percent owner	Buy	2024-05-13	253,700	$1.24	$313.3K
Golipour Azadeh	officer: Chief Technology Officer	M-Exempt	2024-02-01	37,334	—	—
Golipour Azadeh	officer: Chief Technology Officer	M-Exempt	2024-02-01	37,334	—	—
Golipour Azadeh	officer: Chief Technology Officer	F-InKind	2024-02-05	12,232	$1.20	$14.7K
Ridha Essra	officer: Chief Medical Officer	M-Exempt	2024-02-01	32,834	—	—
Ridha Essra	officer: Chief Medical Officer	M-Exempt	2024-02-01	32,834	—	—
Ridha Essra	officer: Chief Medical Officer	F-InKind	2024-02-05	16,953	$1.20	$20.4K
Ostrowski Erik	officer: Interim CEO, President and CFO	M-Exempt	2024-02-01	40,084	—	—

Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.

🔬

Financial Health Scores

Altman Z-Score

-0.72

🔴 Distress Zone — elevated dividend cut risk

Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81

Piotroski F-Score

4/9

⚠️ Moderate fundamentals

Strong: 7–9 · Moderate: 4–6 · Weak: 0–3

Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.

📊 About This Data

Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.

🔄 Updated daily🔒 SEC EDGAR source✍️ Reviewed by Victor Strand

📊 Data via FMP🔒 SEC EDGAR🔄 Updated daily✍️ Reviewed by Victor Strand 📬 Report data error

Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AVRO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →